Published in Int J Neuropsychiatry on February 01, 1968
Toward a neurobiology of delusions. Prog Neurobiol (2010) 1.70
Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy. Drug Alcohol Depend (2012) 0.79
Amphetamine psychosis or paranoid schizophrenia? West J Med (1975) 0.75
Cocaine and other stimulants. Actions, abuse, and treatment. N Engl J Med (1988) 3.98
Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev (2001) 1.90
Hypercortisolemia and hippocampal changes in depression. Psychiatry Res (1993) 1.52
Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. Arch Gen Psychiatry (1992) 1.41
Hippocampal abnormalities in depression. J Neuropsychiatry Clin Neurosci (1991) 1.19
Narcotic addiction among physicians: a ten-year follow-up. Am J Psychiatry (1966) 1.18
Neuroanatomical substrates of depression in the elderly. Eur Arch Psychiatry Clin Neurosci (1993) 1.17
Pituitary size in depression. J Clin Endocrinol Metab (1991) 1.16
Amphetamine stereotypy: the influence of environmental factors and prepotent behavioral patterns on its topography and development. Biol Psychiatry (1975) 1.10
Rating the behavioral effects of amphetamine. Eur J Pharmacol (1974) 1.08
Assault and homicide associated with amphetamine abuse. Am J Psychiatry (1971) 1.05
Evolving behavior in the clinical and experimental amphetamine (model) psychosis. Am J Psychiatry (1973) 1.01
Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam. Psychopharmacology (Berl) (1985) 1.01
Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam. J Pharmacokinet Biopharm (1990) 1.00
Cocaine dependence. Annu Rev Med (1989) 1.00
Effects of marijuana on performance of a computerized cognitive-neuromotor test battery. Psychiatry Res (1994) 1.00
Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry (1988) 0.99
Auditory habituation at primary cortex as a function of stimulus rate. Exp Neurol (1968) 0.94
Modeling the pharmacokinetics and pharmacodynamics of dexamethasone in depressed patients. Eur J Clin Pharmacol (1992) 0.94
Fundamental mechanisms underlying altered behavior following chronic administration of psychomotor stimulants. Biol Psychiatry (1980) 0.92
Posterior fossa abnormalities in major depression: a controlled magnetic resonance imaging study. Acta Psychiatr Scand (1992) 0.92
Stimulants: interaction with clinically relevant drugs. Ann N Y Acad Sci (1976) 0.91
Differential time-course profiles of dopamine release and uptake changes induced by three dopamine uptake inhibitors. Synapse (2001) 0.90
Intermittent and continuous cocaine administration: residual behavioral states during withdrawal. Pharmacol Biochem Behav (1992) 0.89
MR assessment of pituitary gland morphology in healthy volunteers: age- and gender-related differences. AJNR Am J Neuroradiol (1992) 0.89
Alcohol pharmacodynamics in young-elderly adults contrasted with young and middle-aged subjects. Psychopharmacology (Berl) (1995) 0.89
In vivo assessment of pituitary gland volume with magnetic resonance imaging: the effect of age. J Clin Endocrinol Metab (1990) 0.89
Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment. Psychopharmacology (Berl) (1996) 0.88
In vivo stereological assessment of caudate volume in man: effect of normal aging. Life Sci (1990) 0.88
Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects. J Neuropsychiatry Clin Neurosci (1991) 0.88
In vivo stereological assessment of human cerebellar volume: effects of gender and age. AJNR Am J Neuroradiol (1991) 0.86
Chronic D-amphetamine in nucleus accumbens: lack of tolerance or reverse tolerance of locomotor activity. Life Sci (1981) 0.85
Therapeutic effects of antidepressants in chronic pain. Gen Hosp Psychiatry (1984) 0.85
Cocaine-mediated impairment of cardiac conduction in the dog: a potential mechanism for sudden death after cocaine. J Pharmacol Exp Ther (1990) 0.85
In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. Psychiatry Res (1992) 0.85
A brain magnetic resonance imaging study of pituitary gland morphology in anorexia nervosa and bulimia. Biol Psychiatry (1990) 0.84
Reverse tolerance to stimulant-induced abnormal behavior. Life Sci (1977) 0.84
Augmentation of the behavioral and electrophysiologic response to cocaine by chronic administration in the rat. Exp Neurol (1977) 0.84
Methamphetamine self-administration in the cat. Psychopharmacologia (1976) 0.84
Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides. Neuroscience (1997) 0.83
Cerebral atrophy in bulimia. Biol Psychiatry (1989) 0.82
Effect of cocaine, nomifensine, GBR 12909 and WIN 35428 on carbon fiber microelectrode sensitivity for voltammetric recording of dopamine. J Neurosci Methods (2000) 0.82
Potentiation of the behavioral and convulsant effects of cocaine by chronic administration in the rat. Pharmacol Biochem Behav (1977) 0.82
The effects of chronic cocaine pretreatment on kindled seizures and behavioral stereotypies. Exp Neurol (1979) 0.82
Alterations in baseline activity and quinpirole sensitivity in putative dopamine neurons in the substantia nigra and ventral tegmental area after withdrawal from cocaine pretreatment. Neuropsychopharmacology (1998) 0.82
Profile of acute tolerance to three sedative anxiolytics. Psychopharmacology (Berl) (1983) 0.82
Tricyclic-induced akathisia in patients taking conjugated estrogens. Am J Psychiatry (1984) 0.81
Central nervous system cytopathological changes in cats with chronic methedrine intoxication. Brain Res (1970) 0.81
Emergency department patterns in psychiatric visits during the holiday season. Ann Emerg Med (1994) 0.81
Behavioral analysis of chronic amphetamine intoxication. Biol Psychiatry (1972) 0.81
Acute deleterious effects of cocaine on cardiac conduction, hemodynamics, and ventricular fibrillation threshold: effects of interaction with a selective dopamine D1 antagonist SCH 39166. J Cardiovasc Pharmacol (1998) 0.81
Combining 'caged-dopamine' photolysis with fast-scan cyclic voltammetry to assess dopamine clearance and release autoinhibition in vitro. J Neurosci Methods (1996) 0.81
Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine. Psychopharmacology (Berl) (1997) 0.81
Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder. Biol Psychiatry (1991) 0.80
Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist. Eur J Pharmacol (2000) 0.80
Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function. J Pharmacol Exp Ther (1994) 0.80
Subcortical brain anatomy in anorexia and bulimia. Biol Psychiatry (1992) 0.80
Altered cocaine potency in the nucleus accumbens following 7-day withdrawal from intermittent but not continuous treatment: voltammetric assessment of dopamine uptake in the rat. Psychopharmacology (Berl) (1998) 0.79
MRI of corpus callosum and septum pellucidum in depression. Biol Psychiatry (1991) 0.79
Phase I studies of recombinant interferon-gamma. J Biol Response Mod (1990) 0.79
Altered sensitivity of dopamine autoreceptors in rat accumbens 1 and 7 days after intermittent or continuous cocaine withdrawal. Brain Res Bull (2000) 0.79
Conditioned aversion to a preferred solution following methamphetamine injections. Psychopharmacologia (1973) 0.79
Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine. Psychopharmacology (Berl) (1998) 0.79
Continuous or intermittent cocaine administration: effects of amantadine treatment during withdrawal. Pharmacol Biochem Behav (1994) 0.79
Dopamine efflux during withdrawal from continuous or intermittent cocaine. Psychopharmacology (Berl) (1993) 0.79
Morphometric changes of the human midbrain with normal aging: MR and stereologic findings. AJNR Am J Neuroradiol (1992) 0.78
Effects of single and repeated alcohol withdrawal on kindling. Biol Psychiatry (1984) 0.78
Effect of cocaine on dopamine transporter receptors depends on routes of chronic cocaine administration. Neuropsychopharmacology (1996) 0.78
MRI scans in patients with tardive dyskinesia. Biol Psychiatry (1988) 0.78
Direct, real-time assessment of dopamine release autoinhibition in the rat caudate-putamen. Neuroscience (2002) 0.78
Psychotropic drugs promoting weight gain: health risks and treatment implications. South Med J (1983) 0.78
Neuroanatomical changes and hypothalamo-pituitary-adrenal axis abnormalities. Biol Psychiatry (1989) 0.78
Comparative pharmacodynamics of benzodiazepines. Psychopharmacol Ser (1987) 0.78
Age-related increase in CNS sensitivity to benzodiazepines as assessed by task difficulty. Psychopharmacology (Berl) (1990) 0.78
Conditioned aversion in spatial paradigms following methamphetamine injection. Psychopharmacologia (1974) 0.78
Influence of gamma-butyrolactone on behavior due to dopaminergic drugs. Physiol Behav (1983) 0.78
Cerebral atrophy in anorexia nervosa: a pilot study. Biol Psychiatry (1989) 0.78
Discriminative stimulus properties of psychomotor stimulants in the cat. Psychopharmacology (Berl) (1979) 0.78
Technique for the continuous infusion of high doses of cocaine by osmotic minipump. Pharmacol Biochem Behav (1993) 0.77
Cholinergic modulation of stimulant-induced behavior. Pharmacol Biochem Behav (1984) 0.77
Aging of the human corpus callosum: magnetic resonance imaging in normal volunteers. J Neuropsychiatry Clin Neurosci (1991) 0.77
The effects of continuous cocaine dose on the induction of behavioral tolerance and dopamine autoreceptor function. Eur J Pharmacol (1999) 0.77
Withdrawal from continuous or intermittent cocaine: effects of NAN-190 on cocaine-induced locomotion. Pharmacol Biochem Behav (1993) 0.77
Quaalude alley: a one-way street. Am J Psychiatry (1973) 0.77
Habituation of evoked response to uniaural clicks. Brain Res (1968) 0.77
Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam. Psychopharmacology (Berl) (1997) 0.77
Blockade of accumbens 5-HT3 receptor down-regulation by ondansetron administered during continuous cocaine administration. Eur J Pharmacol (1999) 0.77
Brain T1 measured by magnetic resonance imaging in bulimia. Biol Psychiatry (1990) 0.77
Narcotic addicts in the mid-1960's. Public Health Rep (1966) 0.77
Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine. Mol Pharmacol (1994) 0.77
Amphetamine abuse. Science (1971) 0.76
Continuous or intermittent cocaine administration: effects of flupenthixol treatment during withdrawal. Pharmacol Biochem Behav (1994) 0.76
Altered activity of midbrain dopamine neurons following 7-day withdrawal from chronic cocaine abuse is normalized by D2 receptor stimulation during the early withdrawal phase. Neuropsychopharmacology (1999) 0.76
5-HT3 agonist-induced dopamine overflow during withdrawal from continuous or intermittent cocaine administration. Psychopharmacology (Berl) (1995) 0.76
Chronic continuous or intermittent infusion of cocaine differentially alter the concentration of neurotensin-like immunoreactivity in specific rat brain regions. Neuropsychopharmacology (1993) 0.76
Assessment of posterior fossa structures with midsagittal MRI: the effects of age. Neurobiol Aging (1992) 0.76
Tolerance to cocaine-induced convulsions in the cat. Eur J Pharmacol (1978) 0.76
Withdrawal from continuous or intermittent cocaine: behavioral responsivity to 5-HT1 receptor agonists. Pharmacol Biochem Behav (1993) 0.76
Comparison of the effects of quazepam and triazolam on cognitive-neuromotor performance. Psychopharmacology (Berl) (1987) 0.76
Persistent elevation of thyroid-stimulating hormone in women with bipolar affective disorder. Am J Psychiatry (1982) 0.76